Lucid Diagnostics Inc (LUCD) financials
Lucid Diagnostics revenue and earnings by year
Lucid Diagnostics's revenue was $4.71 million in the fiscal year to December 31, 2025, up 8.3% from the year before. Net income was -$58.0 million, -1232.7% of revenue. Since the fiscal year to December 31, 2021, revenue has grown 75.2% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 5 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 5 | 4 | 2 | 0 | 1 |
| Revenue growth | 8.3% | 79.0% | 544.0% | -24.6% | — |
| Gross profit | -2 | -3 | -4 | -3 | -0 |
| Gross margin | -41.7% | -63.3% | -146.3% | -858.6% | -17.0% |
| Operating income | -50 | -46 | -48 | -56 | -27 |
| Operating margin | -1054.8% | -1059.6% | -1996.8% | -14920.7% | -5483.8% |
| Net income | -58 | -46 | -53 | -56 | -28 |
| Net margin | -1232.7% | -1047.6% | -2169.1% | -14899.5% | -5615.6% |
| Diluted EPS | -$0.69 | -$1.05 | -$1.26 | -$1.55 | -$1.51 |
| Free cash flow | -47 | -44 | -33 | -31 | -19 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open LUCD in Markets.
See also: LUCD returns
No forecast, no recommendation. This page describes Lucid Diagnostics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.